Key facts
- Seegene launched the Allplex MDRO Assay.
- The assay has IVDR marking, indicating compliance with European regulations.
- This expands Seegene's antimicrobial resistance testing portfolio in Europe.
- The assay allows for rapid PCR screening of high-risk multidrug-resistant organisms in hospitals.
- It contributes to infection prevention efforts.
The launch of the Allplex MDRO Assay by Seegene, marked with IVDR, signifies an expansion in the European market for antimicrobial resistance testing. This development aims to address the growing challenge of multidrug-resistant organisms (MDROs) in healthcare settings by providing a rapid diagnostic tool.